Prime.io welcomes Sir Tony Kouzarides as a Scientific Advisor
Prime.io - a london based cell line engineering service CRO company appoints Sir Tony Kouzarides to support long-term strategy for its Next Generation Cell Line Engineering Services.
Tony is a highly cited academic and entrepreneur who co-founded both the Milner Therapeutics Institute and Abcam (NASDAQ: ABCM). As scientific advisor, he will help guide prime.io's scientific strategy and explore new opportunities to raise awareness of the Company’s mission to edit genes and accelerate drug discovery.